’s largest middlemen are starting to attract   scrutiny for their role in drug pricing. Their response: to   come out swinging, and point the finger elsewhere. " ’   Pharmacy benefit managers are the companies  to the prices drugmakers set, and are   meant to favor the most effective drug. 